Article Details
Retrieved on: 2024-07-23 21:09:37
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses a study on long-acting injectable cabotegravir (CAB-LA) as a safe and effective HIV pre-exposure prophylaxis (PrEP) method for cisgender women during pregnancy. This ties into concepts of pregnancy, HIV prevention, and sexual and reproductive health.
Article found on: www.poz.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here